2019 Q1 Form 10-Q Financial Statement
#000156459019016580 Filed on May 07, 2019
Income Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | -100.0% | |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $2.620M | $2.240M |
| YoY Change | 16.96% | 6.67% |
| % of Gross Profit | ||
| Research & Development | $9.140M | $5.568M |
| YoY Change | 64.15% | -5.68% |
| % of Gross Profit | ||
| Depreciation & Amortization | $80.00K | $150.0K |
| YoY Change | -46.67% | -11.76% |
| % of Gross Profit | ||
| Operating Expenses | $11.76M | $5.568M |
| YoY Change | 111.21% | -30.43% |
| Operating Profit | -$7.818M | |
| YoY Change | -2.12% | |
| Interest Expense | $358.0K | $159.0K |
| YoY Change | 125.16% | -66.17% |
| % of Operating Profit | ||
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$11.30M | -$3.743M |
| YoY Change | 202.0% | -50.23% |
| Income Tax | $37.00K | $12.00K |
| % Of Pretax Income | ||
| Net Earnings | -$11.34M | -$3.755M |
| YoY Change | 202.02% | -50.05% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | -$0.21 | |
| Diluted Earnings Per Share | -$440.4K | -$0.21 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 17.80M | |
| Diluted Shares Outstanding | 17.80M |
Balance Sheet
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $110.4M | $35.10M |
| YoY Change | 214.53% | -39.48% |
| Cash & Equivalents | $52.20M | $17.20M |
| Short-Term Investments | $58.20M | $17.90M |
| Other Short-Term Assets | $1.500M | $1.200M |
| YoY Change | 25.0% | 33.33% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $100.0K | $400.0K |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $112.0M | $36.70M |
| YoY Change | 205.18% | -37.9% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $2.400M | $1.100M |
| YoY Change | 118.18% | -21.43% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $100.0K | $0.00 |
| YoY Change | -100.0% | |
| Total Long-Term Assets | $2.600M | $1.100M |
| YoY Change | 136.36% | -35.29% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $112.0M | $36.70M |
| Total Long-Term Assets | $2.600M | $1.100M |
| Total Assets | $114.6M | $37.80M |
| YoY Change | 203.17% | -37.83% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.100M | $500.0K |
| YoY Change | 120.0% | -58.33% |
| Accrued Expenses | $5.200M | $1.900M |
| YoY Change | 173.68% | -17.39% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $1.400M | |
| YoY Change | ||
| Total Short-Term Liabilities | $6.400M | $3.800M |
| YoY Change | 68.42% | 5.56% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $15.14M | $5.500M |
| YoY Change | 175.25% | |
| Other Long-Term Liabilities | $700.0K | |
| YoY Change | ||
| Total Long-Term Liabilities | $15.14M | $5.500M |
| YoY Change | 175.25% | |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $6.400M | $3.800M |
| Total Long-Term Liabilities | $15.14M | $5.500M |
| Total Liabilities | $22.20M | $9.300M |
| YoY Change | 138.71% | 158.33% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$219.4M | |
| YoY Change | ||
| Common Stock | $305.0M | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $92.31M | $28.50M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $114.6M | $37.80M |
| YoY Change | 203.04% | -37.83% |
Cashflow Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$11.34M | -$3.755M |
| YoY Change | 202.02% | -50.05% |
| Depreciation, Depletion And Amortization | $80.00K | $150.0K |
| YoY Change | -46.67% | -11.76% |
| Cash From Operating Activities | -$8.667M | -$8.219M |
| YoY Change | 5.45% | 27.23% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $335.0K | $181.0K |
| YoY Change | 85.08% | 32.12% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$6.670M | $5.160M |
| YoY Change | -229.26% | -44.99% |
| Cash From Investing Activities | -$7.032M | $4.977M |
| YoY Change | -241.29% | -46.19% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 60.00K | 120.0K |
| YoY Change | -50.0% | -29.41% |
| NET CHANGE | ||
| Cash From Operating Activities | -8.667M | -8.219M |
| Cash From Investing Activities | -7.032M | 4.977M |
| Cash From Financing Activities | 60.00K | 120.0K |
| Net Change In Cash | -15.70M | -3.242M |
| YoY Change | 384.24% | -209.53% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$8.667M | -$8.219M |
| Capital Expenditures | $335.0K | $181.0K |
| Free Cash Flow | -$9.002M | -$8.400M |
| YoY Change | 7.17% | 27.33% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2019Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
| CY2019Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | |
| CY2019Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1233000 | |
| CY2019Q1 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
72000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
105000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
582000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
722000 | |
| CY2019Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
15139000 | |
| CY2018Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
15014000 | |
| CY2019Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7732000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7732000 | |
| CY2019Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
266040000 | |
| CY2019Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
38932000 | |
| CY2019Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-219401000 | |
| CY2019Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-990000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
92313000 | |
| CY2019Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
114550000 | |
| CY2019Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q1 | us-gaap |
Preferred Stock No Par Value
PreferredStockNoParValue
|
||
| CY2019Q1 | us-gaap |
Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
|
Unlimited | |
| CY2019Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
1016000 | |
| CY2019Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
1016000 | |
| CY2019Q1 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
| CY2019Q1 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
| CY2019Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25771954 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25771954 | |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5568000 | |
| CY2019Q1 | us-gaap |
Interest Expense
InterestExpense
|
358000 | |
| CY2018Q1 | us-gaap |
Interest Expense
InterestExpense
|
159000 | |
| CY2018Q1 | us-gaap |
Gain Loss On Contract Termination
GainLossOnContractTermination
|
4398000 | |
| CY2019Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11304000 | |
| CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-3743000 | |
| CY2019Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
37000 | |
| CY2018Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
12000 | |
| CY2018Q1 | xene |
Net Income Loss Available To Preferred Stockholders Basic
NetIncomeLossAvailableToPreferredStockholdersBasic
|
33000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
35934000 | |
| CY2018Q1 | us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
4470000 | |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
670000 | |
| CY2019Q1 | us-gaap |
Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
|
-175000 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
58000 | |
| CY2018Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-3755000 | |
| CY2018Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
72000 | |
| CY2019Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
33000 | |
| CY2018Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-37000 | |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
491000 | |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
663000 | |
| CY2018Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-267000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-230000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1560000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1016000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-8667000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-8219000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
335000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
181000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
34325000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
8148000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
27628000 | |
| CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
13306000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-7032000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
4977000 | |
| CY2018Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17200000 | |
| CY2019Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
230000 | |
| CY2018Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
71000 | |
| CY2019Q1 | us-gaap |
Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
|
709000 | |
| CY2018Q1 | us-gaap |
Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
|
141000 | |
| CY2019Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
158000 | |
| CY2018Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
152000 | |
| CY2019Q1 | xene |
Fair Value Of Stock Options Exercised On Cashless Basis
FairValueOfStockOptionsExercisedOnCashlessBasis
|
7000 | |
| CY2018Q1 | xene |
Fair Value Of Stock Options Exercised On Cashless Basis
FairValueOfStockOptionsExercisedOnCashlessBasis
|
176000 | |
| CY2018Q1 | us-gaap |
Stock Issued1
StockIssued1
|
21825000 | |
| CY2019Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td> <td valign="top"> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Basis of presentation:</p></td></tr></table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements are presented in U.S. dollars.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has one wholly-owned subsidiary as of March 31, 2019, Xenon Pharmaceuticals USA Inc., which was incorporated in Delaware on December 2, 2016.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These unaudited interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany transactions and balances have been eliminated on consolidation. Certain prior year amounts have been reclassified to conform to the current year presentation.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited interim consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these consolidated financial statements do not include all of the information and footnotes required for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements and notes for the year ended December 31, 2018 and included in the Company’s 2018 Annual Report on Form 10-K filed with the SEC and with the securities commissions in British Columbia, Alberta and Ontario on March 6, 2019.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These unaudited interim consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for a fair presentation of results for the interim periods presented. The results of operations for the three months ended March 31, 2019 and 2018 are not necessarily indicative of results that can be expected for a full year. These unaudited interim consolidated financial statements follow the same significant accounting policies as those described in the notes to the audited consolidated financial statements of the Company included in the Company’s 2018 Annual Report on Form 10-K for the year ended December 31, 2018, with the exception of the policy described in note 3 below. </p> | |
| CY2019Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
109000 | |
| CY2019Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
179000 | |
| CY2019Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y | |
| CY2019Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0375 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
466000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
621000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
587000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
140000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1814000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
78000 | |
| CY2019Q1 | xene |
Future Lease Incentives Reasonably Certain Of Use
FutureLeaseIncentivesReasonablyCertainOfUse
|
432000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1304000 | |
| CY2019Q1 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1071000 | |
| CY2019Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
784000 | |
| CY2019Q1 | xene |
Accrued Consulting And Contracted Research Current
AccruedConsultingAndContractedResearchCurrent
|
3551000 | |
| CY2018Q4 | xene |
Accrued Consulting And Contracted Research Current
AccruedConsultingAndContractedResearchCurrent
|
1404000 | |
| CY2019Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
250000 | |
| CY2019Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
138000 | |
| CY2019Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
5167000 | |
| CY2019Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
6200000 | |
| CY2019Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
4133000 | |
| CY2019Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
15500000 | |
| CY2018Q1 | us-gaap |
Gain Loss On Contract Termination
GainLossOnContractTermination
|
4398000 | |
| CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2671906 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
21900 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
22402 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
3955 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2667449 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1769984 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2339905 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
563700 | |
| CY2018Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
84668 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
22996 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2795941 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1505459 | |
| CY2019Q1 | xene |
Stock Options Exercised For Number Of Common Shares For Cash
StockOptionsExercisedForNumberOfCommonSharesForCash
|
20576 | |
| CY2018Q1 | xene |
Stock Options Exercised For Number Of Common Shares For Cash
StockOptionsExercisedForNumberOfCommonSharesForCash
|
13374 | |
| CY2019Q1 | xene |
Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
|
657 | |
| CY2018Q1 | xene |
Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
|
27507 | |
| CY2019Q1 | xene |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
1826 | |
| CY2018Q1 | xene |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
71294 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0258 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0277 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.76 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.75 | |
| CY2019Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M7D | |
| CY2018Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P7Y4M9D | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.34 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.41 |
